𝔖 Bobbio Scriptorium
✦   LIBER   ✦

What are cancer patients willing to pay for prophylactic epoetin alfa?—A cost-benefit analysis

✍ Scribed by Bülent Orhan; Şuayib Yalçin


Publisher
John Wiley and Sons
Year
1999
Tongue
English
Weight
39 KB
Volume
86
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


What are cancer patients willing to pay
✍ Ana Ortega; George Dranitsaris; Anitasha L. V. Puodziunas 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 98 KB

BACKGROUND. Anemia, one of the most common complications of cancer chemotherapy, has been managed with red blood cell (RBC) transfusions. As an alternative, the agent epoetin alfa has the potential to reduce the transfusion requirements of patients receiving cancer chemotherapy. To estimate the valu